Jianyu Weng

7PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical biotechnology not elsewhere classifiedGene and molecular therapyMedical mycologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 09, 2025
Comparing the efficacy and safety of the ABC-14 regimen (azacitidine, venetoclax, and chidamide) with traditional "3 + 7" intensive induction regimen or AB-14 regimen (venetoclax combined with azacitidine) in newly diagnosed AML: study protocol for a prospective, multicenter, randomized, open-label clinical trial.

Honghong Yan, Xin Huang, Ping Wu

|Jul 09, 2024
Identification of a Novel <i>MAPK1::BCR</i> Fusion Gene/t(9;22) (q34;q11) in a Case of Acute Promyelocytic Leukemia

Qian Wang, Ling-Ji Zeng, Man Wang

|Dec 22, 2023
Outcomes of intermediate or high-risk CMML patients treated with hypomethylating agents combined with venetoclax: A single center experience.

Chao Li, ChengXin Deng, Ping Wu

|Apr 25, 2023
Mesenchymal stem cells reversibly de-differentiate myofibroblasts to fibroblast-like cells by inhibiting the TGF-β-SMAD2/3 pathway.

Ruohao Xu, Miao Wu, Yawen Wang

|Mar 27, 2023
Validation of the imatinib-therapy failure model.

Xiaoshuai Zhang, Robert Peter Gale, Bingcheng Liu

|Mar 29, 2021
C-Type Lectin-Like Molecule-1 as a Biomarker for Diagnosis and Prognosis in Acute Myeloid Leukemia: A Preliminary Study.

Jinghua Wang, Weida Wang, Hao Chen

Pageof 2

Frequent Collaborators

1 joint publications

Qian Wang

1 joint publications

Ling-Ji Zeng

1 joint publications

Man Wang

1 joint publications

Jin-Lan Pan